Focused on GU. Focused on You.
GU stands for genitourinary: cancers of the prostate, bladder, kidney and testicles. The Tennessee Oncology GU Center of Excellence brings together specialists who provide coordinated care from diagnosis through survivorship, delivered by experts, driven by innovation, and centered around you.
A cancer diagnosis comes with questions. We’re here with answers and options.
Nationally accredited cancer care
Coordinated medical & radiation oncology
In-person care in Franklin, TN
Access to GU clinical trials
A genitourinary cancer diagnosis often involves more than one specialist. Our team is structured so those specialists work together on your case, not in isolation.
Medical oncology, radiation oncology, and imaging teams coordinate on a single treatment plan, so you spend less time repeating your history to disconnected providers.
Genetic and biomarker testing, advanced imaging, and a range of treatment options, from active surveillance to systemic therapy to radiation, matched to your specific diagnosis.
Our team screens for clinical trial eligibility at every visit, giving patients access to emerging therapies not available everywhere.
Medical oncology, radiation oncology, and cardio-oncology specialists who review your case together.
Founding physician lead of the GU Center of Excellence, treating prostate, bladder, kidney, and testicular cancer. Chairs the GU Disease Group at OneOncology and leads a team with more than a dozen GU clinical trials open. MD and PhD from Vanderbilt University.
Provides external beam radiation therapy, SBRT, and brachytherapy for prostate cancer, and collaborates with the Tennessee Oncology Proton Center for proton therapy when clinically indicated. Board certified by the American Board of Radiology; trained at Vanderbilt University School of Medicine and the Harvard Radiation Oncology Program.
Provides cardiovascular monitoring and risk management for patients on cardiotoxic GU cancer therapies, including androgen deprivation therapy. Board certified in cardiovascular disease, internal medicine, and interventional cardiology; trained at the University of Colorado and Duke University Medical Center.
Located in Franklin, TN, the Tennessee Oncology Proton Center offers advanced proton therapy, a precise, targeted radiation treatment option for prostate and other cancers. It’s part of Tennessee Oncology’s coordinated GU care network, giving patients access to leading-edge treatment close to home.
4588 Carothers Parkway, Franklin, TN 37067
Each GU cancer has its own pattern of warning signs. Knowing them can help you seek care sooner, and earlier diagnosis generally means more treatment options.
Prostate cancer is the most commonly diagnosed cancer among American men aside from skin cancer. Early-stage disease is frequently asymptomatic, which is why both screening conversations and awareness of subtle symptom changes matter.
These symptoms are considerably more likely to result from an enlarged prostate or infection than cancer, but persistent or new symptoms should always be evaluated by a physician. The American Cancer Society estimates about 1 in 8 men will be diagnosed with prostate cancer in his lifetime.
Bladder cancer is often found earlier than many other cancers because it tends to produce a symptom that leads people to see a doctor, most often blood in the urine.
Early bladder cancer often causes bleeding with little or no pain, which is exactly why any blood in the urine deserves evaluation rather than being dismissed. Bladder cancer is diagnosed roughly 3-4 times more often in men than women.
Early kidney cancer usually causes no symptoms at all, and many cases are first found incidentally during imaging done for an unrelated reason. Larger or more advanced tumors are more likely to produce noticeable symptoms.
There is no recommended routine screening test for kidney cancer in average-risk adults, which makes awareness of these signs especially important. Kidney cancer is diagnosed roughly twice as often in men as in women.
Testicular cancer is one of the most treatable cancers when caught early, and it most often affects younger men between their teens and their 40s, an age group less likely to have regular checkups.
Most testicular tumors are painless, which can lead to delayed diagnosis. Any new lump or change should be evaluated promptly. The five-year survival rate for localized testicular cancer is around 95%.
This information is educational and does not replace a medical evaluation. Many of these symptoms are more often caused by non-cancerous conditions, but any new or persistent symptom should be checked by a physician.
Call our team directly, or send us a few details and someone will reach out to help schedule your visit.
Our team is reachable at 615-460-3803, available during normal business hours.